Recently, it was shown that c-Myc protein undergoes acetylation and c-Myc downregulation occurs ex vivo in primary AML samples treated with HDAC inhibitors (Lin et al., 2007). The gene discussed is HDAC9; the disease is acute myeloid leukemia.